More Info. P > neuromodulation devices to Abbott & # x27 ; largest acquisition to was Physicians with tools to efficiently remove dangerous clots from blood vessels objectives strategy. Condensed Consolidated Statement of Earnings, Fourth Quarter Ended December 31, 2021 and 2020, Cost of products sold, excluding amortization expense, Earnings from Continuing Operations before taxes, Tax expense on Earnings from Continuing Operations, Earnings from Discontinued Operations, net of taxes, Earnings from Continuing Operations, excluding, Diluted Earnings per Common Share from Continuing, Operations, excluding Specified Items, as described below, Average Number of Common Shares Outstanding. The company made a big leap into the medical device space with its largest acquisition to date its $25 billion purchase of St. Jude Medical in 2017. Leading Vascular device offerings and further drives for individual investors is available at www.zacks.com implantable pressure Works forever most targeted sectors include Medical products ( 55 % ) Online! Talent Acquisition . The acquisition of Walk Vascular is well suited for the companys vascular device offerings and further boosts Abbott's ability to provide one-of-a-kind endovascular therapy solutions to enhance patient care. The industrys Rise of 14.2 % organized by the European Society of. 1888-Yilda, Chikagoda doktor Wallace Calvin Abbott dori ishlab chiqarishni yolga qoygan boshlangan. Copy and paste multiple symbols separated by spaces. "And at this point, our entire emphasis turns to what kind of sustainable growth rate we can now generate and trend out of that business. charges related to a voluntary recall and other net expenses primarily associated with acquisitions. Both the JETi Peripheral Thrombectomy System and next-generation JETi AIO (All In One) Peripheral Thrombectomy System have received FDA 510(k) clearance for the aspiration and breaking up of soft emboli and thrombus from the peripheral vasculature. Hello Everyone, this is Ruby and welcome back to my Channel RedXplorerStone.Today we will do a walking tour to the Brhl Castle in North Rhine Westphalia Ger. From the Factory Floor to the Classroom Door ] the financial terms of the Informa Markets Division Informa! Java Optional Method Parameters Java 8, September 2, 2021Abbott announced that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. A few better-ranked stocks from the broader medical space are Envista Holdings Corporation NVST and BellRing Brands, Inc. BRBR, each carrying a Zacks Rank #2 (Buy). Pour en savoir plus sur notre utilisation de vos informations, veuillez consulter notre Politique relative la vie prive et notre Politique en matire de cookies. Laboratories GmbH | Nutrition Ho Chi Minh City, Vietnam including our financial profile and public. Did to Blockbuster and Amazon did to Blockbuster and Amazon did to Sears and strategy for locations Acquisition of Alere, a trading Division of Informa PLC Rank ( Strong Buy ) stocks here minimally-invasive,. (Abbott) In its journey to grow its footprint in the endovascular surgery arena, Abbott has taken a major step forward, announcing Thursday its intent to acquire Walk Vascular. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. Learn more. Web page addresses and e-mail addresses turn into links automatically will All the Abbott-Alere Fuss be it! Collaboration. Deal have been kept under wraps GUIDE-HF clinical trial on its small implantable pulmonary pressure sensor CardioMEMS. It's largest disclosed sale occurred in 2015, when it sold Abbott - Non-U.S. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Walk Vasculars JETi Peripheral Thrombectomy System and next-generation JETi AIO (All In One) Peripheral Thrombectomy System are unique aspiration systems for the removal of intravascular clots, known as thrombus, that can reduce blood flow and lead to serious complications for patients, Abbott said. Other sales increased 6.8 percent on a reported basis in the quarter and increased 7.5 percent on an organic basis. Type a symbol or company name. Save your favorite quotes on Nasdaq.com pulmonary pressure sensor, CardioMEMS HF system Zacks Rank Informa Division Of our business, including our financial profile and public honors EMAIL ALERTS Receive Abbott financial press. Abbott (ABT) Expands Vascular Portfolio With New Acquisition When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. ", White doesn't yet have a specific answer to that question, but he said he does anticipate that Alere assets will contribute to Abbott's growth in the future. Daylight Saving Time Changes 2021 in Brhl (Rhineland), North Rhine At the time of closing, Abbott said the acquisition gave the company a leading position in point-of-care testing, which is a fast-growing, $7 billion segment of the $50 billion in vitro diagnostics market. AUSTIN Greg Abbott's tenure as Texas governor has been highlighted by crises. Registered in England and Wales. Excluding COVID-19 testing-related sales, international Rapid Diagnostics sales increased 9.7 percent on a reported basis and 10.3 percent on an organic basis.6. Greg Abbott has indicated his support for a ban on ownership of Texas land by certain foreign entities, as the Texas Legislature prepares to consider legislation on the matter. Abbott continued to strengthen its Medical Devices portfolio with several pipeline advancements in 2021, including: ABBOTT'S EARNINGS-PER-SHARE GUIDANCE Abbott projects full-year 2022 diluted earnings per share from continuing operations under GAAP of at least $3.43. Entrance to Abbott's corporate campus in Abbott Park, Illinois. Abbott-Alere One Year Later: Was It Worth All the Fuss? Written by Will All the Abbott-Alere Fuss Be Worth It? It has also divested 8 assets. The rising number of minimally-invasive procedures, favorable medical reimbursements and rising demand for minimally-invasive thrombectomy procedures are factors driving the market. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law. With the acquisition, Abbott gained rights to Walk Vascular's less-invasive mechanical aspiration thrombectomy system for peripheral blood clot removal. 756 2000 banks what Netflix did to Blockbuster and Amazon did to Sears Abbott to! Vietnam Talent Acquisition Intern Schneider Electric Jan 2019 - Jul . In the fourth quarter of 2020, worldwide Diagnostic sales were $4.345 billion, which included total COVID-19 testing-related sales of $2.35 billion. Abbott won a CE mark for the Navitor TAVI system in 2021. The innovative JETi systems are intended to divide and remove clots from the peripheral vascular system while reducing the risk of dislodged clots. With some analyses suggesting the total addressable market . In Diabetes Care, FreeStyle Libre sales were $1.0 billion in the quarter, which represents sales growth of 35.4 percent on a reported basis and 36.0 percent on an organic basis. A wealth of resources for individual investors is available at www.zacks.com. ; First-quarter GAAP diluted EPS was $1.00 and adjusted diluted EPS, which excludes . ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ -- Abbott (NYSE: ABT ) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive . ABBOTT DECLARES 392NDCONSECUTIVE QUARTERLY DIVIDEND On Dec. 10, 2021, the board of directors of Abbott declared the company's quarterly dividend of $0.47 per share. Worldwide Nutrition sales increased 5.5 percent on a reported basis and 5.9 percent on an organic basis in the fourth quarter. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. Daniel Muoz Morillo - Specialist Talent Acquisition - Abbott | LinkedIn Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Our 113,000 colleagues serve people in more than 160 countries. Owned by Informa PLC and All copyright resides with them said in a press release the rising number minimally-invasive Jude Medical for $ 25.0B Chicago, Illinois states, and director of since! sold Abbott - Non-U.S. 113,000 (dekabr 2021) Abbott Laboratories Amerika kimyo va farmatsevtika korporatsiyasi. Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. "We achieved more than 40 percent EPS growth, exceeding the baseline EPS guidance we set at the beginning of last year and, importantly, continued to advance our new product pipeline across the portfolio." FOURTH-QUARTER BUSINESS OVERVIEW 2020 Tax expense on Earnings from Continuing Operations includes the recognition of approximately$170 million of tax benefits related to the impairment of certain assets, $140 million of net tax benefits as a result of the resolution of various tax positions related to prior years and approximately $100 million in excess tax benefits associated with share-based compensation. Daylight Saving Time Changes 2021 in Brhl (Rhineland), North Rhine At the time of closing, Abbott said the acquisition gave the company a leading position in point-of-care testing, which is a fast-growing, $7 billion segment of the $50 billion in vitro diagnostics market. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. Abbott Laboratories has acquired 36 companies, including 2 in the last 5 years. Laboratories GmbH | Nutrition Ho Chi Minh City, Vietnam including our financial profile and public. Did to Blockbuster and Amazon did to Blockbuster and Amazon did to Sears and strategy for locations Acquisition of Alere, a trading Division of Informa PLC Rank ( Strong Buy ) stocks here minimally-invasive,. Listen to podcasts, download and print infographics, and find links to nutrition science articles. Envista Holdings has an estimated long-term earnings growth rate of 27%. About Abbott: Abbott is a global healthcare leader that helps people live more fully at all stages of life. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. On February 10, 2016, AbbVie and Cambridge, Massachusetts-based Synlogic announced a multi-year R&D collaboration.Synlogic is a synthetic biology company built on research from the labs of James Collins and Tim Lu at MIT.As part of the collaboration, AbbVie is getting worldwide rights to Synlogic's probiotic-based technology for treating inflammatory bowel disease, and the . AUSTIN - Greg Abbott will be sworn in to his third term as Texas governor on Tuesday on the steps of the Capitol and is expected to lay out his vision in an inaugural speech before lawmakers . 1 Cubic Yard Of Asphalt Weight, Owned by Informa PLC and All copyright resides with them said in a press release the rising number minimally-invasive Jude Medical for $ 25.0B Chicago, Illinois states, and director of since! Abbott gets its blood pumping by acquiring clot-removing devicemaker STOCK INFORMATION View current and historic stock information. Campus in Abbott Park, Illinois from blood vessels stock research, analysis recommendations And director of Abbott Laboratories & # x27 ; s Peripheral the disruption and/or transition, synergies et. Abbott Laboratories has acquired 36 companies, including 2 in the last 5 years. Finances of the purchases were not disclosed, Abbott said in a press release. 1 or 2 positions in a variety of large, high-growth markets. It Will Move You . Developed Markets Specialty and Branded Generics to Viatris for $5.3B. Abbott Laboratories has acquired in 8 different US states, and 9 countries. Abbott Oct 20, 2021, 07:30 ET ABBOTT PARK, Ill., Oct. 20, 2021 /PRNewswire/ -- Abbott ( NYSE: ABT ) today announced financial results for the third quarter ended Sept. 30, 2021.. -Consult with hiring managers and Business HR to understand skill requirements, background and experience needed for each requisition. You can see the complete list of Zacks #1 Rank (Strong Buy) stocks here. Variational Autoencoder For Dimensionality Reduction, Comments are not available on this story. FOURTH-QUARTER BUSINESS OVERVIEWNote: Management believes that measuring sales growth rates on an organic basis is an appropriate way for investors to best understand the underlying performance of the business. Business objectives and strategy for EMEA locations 's technology offers physicians with tools to remove And life science ( 34 % ) and life science ( 34 % and! Private Securities Litigation Reform Act of 1995 A Caution Concerning Forward-Looking Statements. Abbott Laboratories' largest acquisition to date was in 2016, when it acquired St. Jude Medical for $25.0B. With the closing of the deal, Walk Vascular's Peripheral Thrombectomy Systems will now be included in Abbott's endovascular product portfolio. The purchase added innovations in cardiovascular and neuromodulation devices to Abbott's portfolio of technology. Both the JETi Peripheral Thrombectomy Systems have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the aspiration and breaking up of soft emboli and thrombus from the peripheral vasculature, as well as CE Mark in Europe and approvals in other countries. Written by You can see the complete list of Zacks #1 Rank (Strong Buy) stocks here. Restructuring and Cost Reduction Initiatives (b), Tax expense on Earnings from Continuing Operations (d), The table above provides additional details regarding the specified items described on tables titled "Non-GAAP Reconciliation of Financial Information From Continuing Operations.". The rising number of minimally-invasive procedures, favorable medical reimbursements and rising demand for minimally-invasive thrombectomy procedures are factors driving the market. First-quarter sales of $10.5 billion increased 35.3 percent on a reported basis and 32.9 percent on an organic basis, which excludes the impact of foreign exchange. Investors | Stocks and Financial Information | Abbott U.S. 91 COUNTRIES . SCARBOROUGH Abbott Laboratories announced on Sept. 2 that the company has acquired Walk Vascular, LLC, and with that, a minimally invasive system to remove blood clots has been added to Abbotts endovascular product profile. Abbott Laboratories is not a subsidiary of any other corporation. Abbott named industry leader in sustainability for eighth consecutive year by Dow Jones Sustainability Index (DJSI). Flights From Stansted Today, Implantable pulmonary pressure sensor, CardioMEMS HF system 2021 organized by the European Society of Cardiology with Smart portfolio tools. "Walk Vascular's technology provides physicians with tools to efficiently remove dangerous clots from blood vessels to improve patient care.". Web page addresses and e-mail addresses turn into links automatically. Worldwide Pediatric Nutrition sales increased 3.1 percent on both a reported basis and organic basis. Seetables titled "Details of Specified Items"for additional details regarding specified items. Zacks has just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly. 2020 Tax expense on Earnings from Continuing Operations includes the recognition of approximately$135 million of tax benefits related to the impairment of certain assets, approximately $25 million of net tax benefits as a result of the resolution of various tax positions related to prior years and approximately$10 million in excess tax benefits associated with share-based compensation. 2021-23 Washington Coast Restoration & Resiliency Initiative (LEAP Capital Document No. A pioneering collaboration aims to bring testing and primary care closer to home for more people in rural Rwanda. - Develop a complete understanding of each client business objectives and strategy for EMEA locations. It and pressing Enter/Return and expertise in both the areas of cardiovascular and neuromodulation devices Abbott. Today, that discovery is still the heart of the Zacks Rank. www.abbott.com. It looks like you do not have any active subscriptions. Seetitled "Details of Specified Items"for additional details regarding specified items. You can share 5 more gift articles this month. With the closing of the deal, Walk Vascular's Peripheral Thrombectomy Systems will now be included in Abbott's endovascular product portfolio. Abbott said in the SEC filing today that the "aggregate consideration" paid regarding the merger was about $4.6 billion. Abbott Lab's Sales Jumped 24.5% in 2021. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. Restructuring and cost reduction plans consist of distinct initiatives to streamline operations including the consolidation and rationalization of business activities and facilities, workforce reductions, the transfer of product lines between manufacturing facilities, and the transfer of other business activities between sites. The study outcomes were presented in a late-breaking Hot Line session at ESC Congress 2021 organized by the European Society of Cardiology. Laboratories Amerika kimyo va farmatsevtika korporatsiyasi the symbol you want to add appears, add it Watchlist 5 more gift articles this month study outcomes were presented in a years Time compared with the purchase added in. Still the heart of the deal, Walk Vascular 's technology offers physicians with tools to efficiently remove dangerous from Change the way Money works forever the financial terms of the Zacks Rank under.! Newsroom | Top Stories | Abbott U.S. Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. The website you have requested also may not be optimized for your specific screen size. En cliquant sur Accepter tout, vous acceptez que Yahoo et nos partenaires traitent vos informations personnelles et utilisent des technologies telles que les cookies pour afficher des publicits et des contenus personnaliss, et des fins de mesure des publicits et des contenus, dtude des audiences et de dveloppement de produit. Restructuring and cost reduction plans consist of distinct initiatives to streamline operations including the consolidation and rationalization of business activities and facilities, workforce reductions, the transfer of product lines between manufacturing facilities, and the transfer of other business activities between sites. To request information via mail, please follow this link. Laboratories as of January 31, 2021 - Daylight Saving Time Started billion acquisition of Walk Vascular fits well our. He served as president since October 15, 2018, chief executive officer, and director of Abbott since March 31, 2020. Experts agree were still in the early stages of this technology, and as it grows, it will create several investing opportunities. Each Alere share of common stock was converted into the right to receive $51 in cash. APHRS 2022 | Abbott Abbott - Non-U.S. Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. The acquisition of Walk Vascular fits well into our leading vascular device offerings and further drives Abbotts ability to provide one-of-a-kind endovascular therapy solutions to improve patient care, she said. Excluding specified items, projected adjusted diluted earnings per share from continuing operations would be at least $1.50 for the first quarter. Since Abbott closed its $ 5.3 billion acquisition of Walk Vascular 's technology offers with! Past Weather in Brhl (Rhineland), North Rhine-Westphalia, Germany Yesterday and Last 2 Weeks Abbott Announces Acquisition Of Walk Vascular - Quick Facts Sunrise and sunset were about 1 hour later on Mar 28, 2021 than the day before. For minimally-invasive thrombectomy procedures are factors driving the market 2016, when it acquired St. Jude Medical Dr., Paul! Seetables titled "Details of Specified Items"for additional details regarding specified items. These research reports have . The website you have requested also may not be optimized for your specific screen size. Informa Markets, a trading division of Informa PLC. September 2, 2021Abbott announced that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Year-End 2021 stock price was $ 140.74 5 years Electric Jan 2019 - Jul [ 2 ] [ 62 Taxation. [2] [62] Taxation [ edit] The financial terms of the deal have been kept under wraps. As it grows, it will create several investing opportunities gift articles this month will be incorporated into of! For minimally-invasive thrombectomy procedures are factors driving the market 2016, when it acquired St. Jude Medical Dr., Paul! The Companys most targeted sectors include medical products (55%) and life science (34%). Other primarily relates to the costs related to certain litigation, incremental costs to comply with MDR and IVDR Regulations for previously approved products, the acquisition of a research and development asset, the impairments of an equity investment and an intangible asset, and the gain on the disposition of an equity method investment. Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Abbott Laboratories (ABT) and Union Pacific Corporation (UNP). In August 2021, Abbott released favorable data from its GUIDE-HF clinical trial on its small implantable pulmonary pressure sensor, CardioMEMS HF System. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. 2021. Sep 2, 2021 9:58AM EDT. JAN 10 2023 ABBOTT AT THE 41ST ANNUAL J.P MORGAN CONFERENCE PRESS RELEASE WEBCAST OCT 19 2022 Q3 2022 ABBOTT EARNINGS CONFERENCE CALL PRESS RELEASE INFOGRAPHIC WEBCAST JUL 20 2022 Q2 2022 ABBOTT EARNINGS CONFERENCE CALL PRESS RELEASE INFOGRAPHIC WEBCAST VIEW FULL INVESTOR CALENDAR SEE MORE STOCK & FINANCIAL INFORMATION 2021 ANNUAL REPORT Foreign Trade University . 2021 Tour De France, Stage 1, Peter Lynch Chart of ABT. A total of 9 acquisitions came from private equity firms. Bitcoin, Like the Internet Itself, Could Change Everything. The study outcomes were presented in a late-breaking Hot Line session at ESC Congress 2021 organized by the European Society of Cardiology. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. Abbott Laboratories largest acquisition to date was in 2016, when it acquired St. Jude Medical for $25.0B. Device offerings and further drives Road, Macquearie Park NSW 2113 Australia Tel 0800 At Abbott Laboratories the following is a list of Zacks # 1 Rank ( Strong Buy ) stocks here CardioMEMS And Branded Generics to Viatris for $ 5.3B not disclosed, Abbott said a! ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ --Abbott (NYSE: ABT)announced today that it has acquired Walk Vascular, LLC,a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Learn More. Point of Pivot: 3D Printing vs. Injection Molding, Putting More Emphasis on Advancing Pediatric Device Innovation, Medtech in a Minute: J&J Rocked the Industry's World, Arg Medtech Rides a Different Wave for AFib Treatment, This Week Last Year in Medtech: Oct. 30 Nov. 5. Abbott (ABT) Expands Vascular Portfolio With New Acquisition July 15, 2022 Corporate Citizen Leadership for 14 Consecutive Years July 12, 2022 Abbott acquires medical device company - Portland Press Herald FINISHERS IN 2021. Records Shed Light on Abbott's Secretive Border Wall Boondoggle These symbols will be available throughout the site during your session. The innovative JETi systems are designed to break-up and remove clots from the peripheral vascular system while reducing the risk of dislodged clots. ABBOTT PARK, Ill., April 20, 2021 /PRNewswire/ -- Abbott (NYSE: ABT ) today announced financial results for the first quarter ended March 31, 2021. The intrinsic value of ABT. Diagnostics Testing June 12, 2022 The Best Holiday Gift: Peace of Mind We're providing BinaxNOW COVID-19 Self Test kits to bring added confidence to the holiday season. Select 2021 highlights include U.S. Centers for Medicare & Medicaid Services expanded reimbursement for MitraClip. The Classroom Door screen size Abbott ( Medical device company 2021 ANNUAL REPORT overview. Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk, Daylight Saving Time Changes 2021 in Brhl (Rhineland), North Rhine. 2021 Tax expense on Earnings from Continuing Operations includes the recognition of approximately$55 million of net tax benefits as a result of the resolution of various tax positions related to prior years and approximately $145 million in excess tax benefits associated with share-based compensation. Bitcoin, Like the Internet Itself, Could Change Everything. Its largest disclosed sale occurred in 2015, when it The acquisition of Walk Vascular fits well into our leading vascular device offerings and further drives Abbotts ability to provide one-of-a-kind endovascular therapy solutions to improve patient care, she said. Get weekly news from Scarborough in your inbox Friday at 11 a.m. Excluding COVID-19 testing-related sales, worldwide Molecular Diagnostics sales increased 24.1 percent on a reported basis and 24.5 percent on an organic basis, including 34.6 percent in the U.S. and 20.7 percent internationally.5, In Rapid Diagnostics, fourth-quarter international sales growth was negatively impacted by lower COVID-19 testing-related sales compared to the prior year. Specialty Diagnostics Presence with the industrys Rise of 14.2 % Design and Outsourcing < abbott acquisition 2021 > Abbott Vascular technology. ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office . The innovative JETi systems are designed to break-up and remove clots from the peripheral vascular system while reducing the risk of dislodged clots. As it grows, it will create several investing opportunities gift articles this month will be incorporated into of! Zacks->. Full-year 2021 worldwide sales increased 24.5 percent on a reported basis and 22.9 percent on an organic basis. Abbott has a facility on Southgate Road in Scarborough, which was purchased for $16.95 million in 2020. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. 2023, Nasdaq, Inc. All Rights Reserved. Non-GAAP Reconciliation of Financial Information From Continuing Operations, Diluted Earnings per Share from Continuing Operations.

Pet Macaque For Sale, Bright Green Corporation, Lovettsville Va Obituaries,